Head-to-head · Value Score
CoreAge Rx vs RxSpan MD
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, RxSpan MD a 86. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-nameRxSpan MD
#8 · Grade A- · Great Deal
Est. first month
$249/mo month-to-month (as low as $175/mo on the 12-month plan)
Save ~82% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 86 — an est. $99/mo first month, with no teaser step-up baked in. RxSpan MD isn't out of it: People who want a wide, doctor-fronted menu with all-inclusive pricing and nationwide coverage, and who will budget against the month-to-month figure rather than the advertised one.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | RxSpan MD |
|---|---|---|
| Value Score | 93 (A+) | 86 (A-) |
| Est. first month | $99/mo | $249/mo month-to-month (as low as $175/mo on the 12-month plan) |
| Save vs brand-name | ~89% | ~82% |
| Semaglutide | $99/mo | $249/mo month-to-month (as low as $175/mo on the 12-month plan) |
| Tirzepatide | $149/mo | $329/mo month-to-month (as low as $243/mo) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | All 50 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
RxSpan MD
A broad, physician-led menu - compounded and oral GLP-1 plus an advertised brand-name lane under a named plastic surgeon - priced at $249 a month for semaglutide, with the advertised low rates attached to a plan.
Why it's a deal
- Available in all 50 states
- Transparent, all-inclusive published pricing — consult, medication, supplies, shipping and support in one price; cancel or change plans anytime, with the card advertising as low as $175/mo on compounded semaglutide for anyone who commits to a plan
- Both injectable and a real oral (capsule) route, on compounded sema/tirz plus an advertised brand-name lane
- Physician-led by a named, board-certified founder (Dr. John Diaz, plastic surgeon); 24/7 unlimited messaging and coaching, free shipping
The fine print
- Compounded semaglutide/tirzepatide are not FDA-approved — not the same as Wegovy, Ozempic, or Zepbound
- Published pricing shown is for the compounded line — brand-name pricing isn't itemized
- Prescription isn't guaranteed — a provider reviews eligibility after checkout
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to RxSpan MD.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.